Mapping the SLP76 interactome in T cells lacking each of the GRB2-family adaptors reveals molecular plasticity of the TCR signaling pathway

Front Immunol. 2023 Mar 15:14:1139123. doi: 10.3389/fimmu.2023.1139123. eCollection 2023.

Abstract

The propagation and diversification of signals downstream of the T cell receptor (TCR) involve several adaptor proteins that control the assembly of multimolecular signaling complexes (signalosomes). The global characterization of changes in protein-protein interactions (PPI) following genetic perturbations is critical to understand the resulting phenotypes. Here, by combining genome editing techniques in T cells and interactomics studies based on affinity purification coupled to mass spectrometry (AP-MS) analysis, we determined and quantified the molecular reorganization of the SLP76 interactome resulting from the ablation of each of the three GRB2-family adaptors. Our data showed that the absence of GADS or GRB2 induces a major remodeling of the PPI network associated with SLP76 following TCR engagement. Unexpectedly, this PPI network rewiring minimally affects proximal molecular events of the TCR signaling pathway. Nevertheless, during prolonged TCR stimulation, GRB2- and GADS-deficient cells displayed a reduced level of activation and cytokine secretion capacity. Using the canonical SLP76 signalosome, this analysis highlights the plasticity of PPI networks and their reorganization following specific genetic perturbations.

Keywords: GRB2-family adaptors; SLP76; T cell signaling; TCR; mass spectrometry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Protein Interaction Maps
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Antigen, T-Cell / metabolism
  • Signal Transduction* / genetics
  • T-Lymphocytes* / metabolism

Substances

  • Receptors, Antigen, T-Cell

Grants and funding

This work was supported by CNRS, INSERM, the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement n° 787300 (BASILIC) to BM), Agence Nationale de la Recherche (LYMPHOSCAN project to RR and SUPERBASILIC project to BM), and by fellowships from DC Biol Labex (ANR-11-LABEX-0043, grant ANR-10-IDEX-0001-02 PSL; NJ. and JCG.), La Ligue (KR). The Marseille Proteomics facility is supported by IBISA (Infrastructures Biologie Santé et Agronomie), Plan Cancer, Canceropôle PACA, Région Sud Provence-Alpes-Côte d’Azur, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Plateforme Technologie Aix-Marseille and Fonds Européen de Développement Régional.